{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T16:12:11Z","timestamp":1791562331750,"version":"4.3.4"},"reference-count":52,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["23116"],"award-info":[{"award-number":["23116"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.bbcan.2021.188675","type":"journal-article","created":{"date-parts":[[2021,12,30]],"date-time":"2021-12-30T21:43:49Z","timestamp":1640900629000},"page":"188675","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Oncosuppressive and oncogenic activity of the sphingolipid-metabolizing enzyme \u03b2-galactosylceramidase"],"prefix":"10.1016","volume":"1877","author":[{"given":"Mirella","family":"Belleri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Chiodelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzia","family":"Corli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Capra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Presta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbcan.2021.188675_bb0005","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1073\/pnas.66.2.302","article-title":"Globoid cell leucodystrophy (Krabbe's disease): deficiency of galactocerebroside beta-galactosidase","volume":"66","author":"Suzuki","year":"1970","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2021.188675_bb0010","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1002\/jnr.23873","article-title":"Biochemical, cell biological, pathological, and therapeutic aspects of Krabbe's disease","volume":"94","author":"Won","year":"2016","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbcan.2021.188675_bb0015","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nrc.2017.96","article-title":"Sphingolipid metabolism in cancer signalling and therapy","volume":"18","author":"Ogretmen","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2021.188675_bb0020","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nrc3398","article-title":"Ceramide-orchestrated signalling in cancer cells","volume":"13","author":"Morad","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2021.188675_bb0025","doi-asserted-by":"crossref","first-page":"729","DOI":"10.3390\/medicina57070729","article-title":"Ceramide metabolism enzymes-therapeutic targets against cancer","volume":"57","author":"Gomez-Larrauri","year":"2021","journal-title":"Medicina"},{"key":"10.1016\/j.bbcan.2021.188675_bb0030","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.trecan.2021.08.001","article-title":"beta-Galactosylceramidase in cancer: friend or foe?","volume":"7","author":"Presta","year":"2021","journal-title":"Trends Cancer"},{"key":"10.1016\/j.bbcan.2021.188675_bb0035","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1093\/hmg\/2.11.1841","article-title":"Cloning and expression of cDNA encoding human galactocerebrosidase, the enzyme deficient in globoid cell leukodystrophy","volume":"2","author":"Chen","year":"1993","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbcan.2021.188675_bb0040","first-page":"665","article-title":"Molecular cloning and knockdown of galactocerebrosidase in zebrafish: new insights into the pathogenesis of Krabbe's disease","volume":"2014","author":"Zizioli","year":"1842","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbcan.2021.188675_bb0045","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0167-4781(97)00140-1","article-title":"Human galactocerebrosidase gene: promoter analysis of the 5'-flanking region and structural organization","volume":"1395","author":"Sakai","year":"1998","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbcan.2021.188675_bb0050","doi-asserted-by":"crossref","first-page":"15169","DOI":"10.1073\/pnas.1105639108","article-title":"Insights into krabbe disease from structures of galactocerebrosidase","volume":"108","author":"Deane","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2021.188675_bb0055","doi-asserted-by":"crossref","first-page":"20479","DOI":"10.1073\/pnas.1311990110","article-title":"Structural snapshots illustrate the catalytic cycle of beta-galactocerebrosidase, the defective enzyme in krabbe disease","volume":"110","author":"Hill","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2021.188675_bb0060","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41467-017-02361-y","article-title":"The mechanism of glycosphingolipid degradation revealed by a GALC-SapA complex structure","volume":"9","author":"Hill","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2021.188675_bb0065","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0009-8981(98)00095-3","article-title":"Expression and processing of recombinant human galactosylceramidase","volume":"276","author":"Nagano","year":"1998","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.bbcan.2021.188675_bb0070","doi-asserted-by":"crossref","first-page":"5489","DOI":"10.1523\/JNEUROSCI.6383-09.2010","article-title":"Molecular characterization of mutations that cause globoid cell leukodystrophy and pharmacological rescue using small molecule chemical chaperones","volume":"30","author":"Lee","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbcan.2021.188675_bb0075","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nrm.2017.107","article-title":"Sphingolipids and their metabolism in physiology and disease","volume":"19","author":"Hannun","year":"2018","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.bbcan.2021.188675_bb0080","doi-asserted-by":"crossref","first-page":"20097","DOI":"10.1073\/pnas.1912108116","article-title":"Genetic ablation of acid ceramidase in krabbe disease confirms the psychosine hypothesis and identifies a new therapeutic target","volume":"116","author":"Li","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2021.188675_bb0085","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1093\/brain\/awt215","article-title":"Inhibition of angiogenesis by beta-galactosylceramidase deficiency in globoid cell leukodystrophy","volume":"136","author":"Belleri","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.bbcan.2021.188675_bb0090","doi-asserted-by":"crossref","first-page":"5011","DOI":"10.1158\/0008-5472.CAN-19-3382","article-title":"Beta-galactosylceramidase promotes melanoma growth via modulation of ceramide metabolism","volume":"80","author":"Belleri","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2021.188675_bb0095","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1750-3639.1995.tb00601.x","article-title":"The twitcher mouse: a model for krabbe disease and for experimental therapies","volume":"5","author":"Suzuki","year":"1995","journal-title":"Brain Pathol."},{"key":"10.1016\/j.bbcan.2021.188675_bb0100","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/jnr.20190","article-title":"Genetic background markedly influences vulnerability of the hippocampal neuronal organization in the \"twitcher\" mouse model of globoid cell leukodystrophy","volume":"77","author":"Tominaga","year":"2004","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbcan.2021.188675_bb0105","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.bbagen.2007.08.010","article-title":"The yin and Yang of lactosylceramide metabolism: implications in cell function","volume":"1780","author":"Chatterjee","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbcan.2021.188675_bb0110","first-page":"779","article-title":"Sphingolipid profile in the CNS of the twitcher (globoid cell leukodystrophy) mouse: a lipidomics approach","volume":"49","author":"Esch","year":"2003","journal-title":"Cell. Mol. Biol."},{"key":"10.1016\/j.bbcan.2021.188675_bb0115","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s11745-014-3945-0","article-title":"GC-EI-MS analysis of fatty acid composition in brain and serum of twitcher mouse","volume":"49","author":"Zanfini","year":"2014","journal-title":"Lipids"},{"key":"10.1016\/j.bbcan.2021.188675_bb0120","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1002\/jnr.23789","article-title":"Metabolic profiling reveals biochemical pathways and potential biomarkers associated with the pathogenesis of krabbe disease","volume":"94","author":"Weinstock","year":"2016","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbcan.2021.188675_bb0125","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1182\/blood-2009-12-256461","article-title":"The galactocerebrosidase enzyme contributes to the maintenance of a functional hematopoietic stem cell niche","volume":"116","author":"Visigalli","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bbcan.2021.188675_bb0130","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1002\/(SICI)1097-0215(19991210)83:6<750::AID-IJC9>3.0.CO;2-V","article-title":"Transcriptional repression of the human galactocerebrosidase gene in squamous cell carcinomas of the larynx","volume":"83","author":"Gorogh","year":"1999","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2021.188675_bb0135","first-page":"11042","article-title":"DNA promoter hypermethylation contributes to down-regulation of galactocerebrosidase gene in lung and head and neck cancers","volume":"8","author":"Peng","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.bbcan.2021.188675_bb0140","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.3892\/or.2015.4134","article-title":"GALC gene is downregulated by promoter hypermethylation in epstein-barr virus-associated nasopharyngeal carcinoma","volume":"34","author":"Zhao","year":"2015","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bbcan.2021.188675_bb0145","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/ijc.20851","article-title":"Implications of galactocerebrosidase and galactosylcerebroside metabolism in cancer cells","volume":"115","author":"Beier","year":"2005","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2021.188675_bb0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0084191","article-title":"Galactosylceramide affects tumorigenic and metastatic properties of breast cancer cells as an anti-apoptotic molecule","volume":"8","author":"Owczarek","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbcan.2021.188675_bb0155","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1084\/jem.20172048","article-title":"Inhibition of UGT8 suppresses basal-like breast cancer progression by attenuating sulfatide-alphaVbeta5 axis","volume":"215","author":"Cao","year":"2018","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbcan.2021.188675_bb0160","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1002\/ijc.24887","article-title":"Therapy for minimal residual tumor disease: beta-galactosylceramide inhibits the growth of recurrent HPV16-associated neoplasms after surgery and chemotherapy","volume":"126","author":"Simova","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2021.188675_bb0165","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00280-008-0896-2","article-title":"Tumor specific cytotoxicity of beta-glucosylceramide: structure-cytotoxicity relationship and anti-tumor activity in vivo","volume":"64","author":"Oku","year":"2009","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.bbcan.2021.188675_bb0170","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3390\/ijms21010251","article-title":"Beta-galactosylceramidase deficiency causes bone marrow vascular defects in an animal model of krabbe disease","volume":"21","author":"Belleri","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2021.188675_bb0175","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.3390\/cancers13061399","article-title":"The role of cancer-associated fibroblasts in tumor progression","volume":"13","author":"Joshi","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2021.188675_bb0180","doi-asserted-by":"crossref","first-page":"380","DOI":"10.3389\/fonc.2020.00380","article-title":"GALC triggers tumorigenicity of colorectal cancer via senescent fibroblasts","volume":"10","author":"Yang","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbcan.2021.188675_bb0185","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.cellsig.2006.07.001","article-title":"Ceramide\/sphingosine\/sphingosine 1-phosphate metabolism on the cell surface and in the extracellular space","volume":"19","author":"Tani","year":"2007","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bbcan.2021.188675_bb0190","doi-asserted-by":"crossref","first-page":"5447","DOI":"10.1039\/C5SM01252J","article-title":"Impact of galactosylceramides on the nanomechanical properties of lipid bilayer models: an AFM-force spectroscopy study","volume":"11","author":"Gumi-Audenis","year":"2015","journal-title":"Soft Matter"},{"key":"10.1016\/j.bbcan.2021.188675_bb0195","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1038\/s41419-019-2117-9","article-title":"Upregulation of IGF2R evades lysosomal dysfunction-induced apoptosis of cervical cancer cells via transport of cathepsins","volume":"10","author":"Takeda","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbcan.2021.188675_bb0200","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3233\/CBM-170995","article-title":"Epithelial-mesenchymal transition and GALC expression of circulating tumor cells indicate metastasis and poor prognosis in non-small cell lung cancer","volume":"22","author":"Liu","year":"2018","journal-title":"Cancer Biomark"},{"key":"10.1016\/j.bbcan.2021.188675_bb0205","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.cell.2013.12.015","article-title":"Dividing cells regulate their lipid composition and localization","volume":"156","author":"Atilla-Gokcumen","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2021.188675_bb0210","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jbior.2014.10.002","article-title":"Roles and regulation of neutral sphingomyelinase-2 in cellular and pathological processes","volume":"57","author":"Shamseddine","year":"2015","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.bbcan.2021.188675_bb0215","first-page":"568","article-title":"Neutral sphingomyelinase 2 heightens anti-melanoma immune responses and anti-PD-1 therapy efficacy, cancer","volume":"9","author":"Montfort","year":"2021","journal-title":"Immunol. Res."},{"key":"10.1016\/j.bbcan.2021.188675_bb0220","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.385","article-title":"Neutral sphingomyelinase (SMPD3) deficiency disrupts the golgi secretory pathway and causes growth inhibition","volume":"7","author":"Stoffel","year":"2016","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbcan.2021.188675_bb0225","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.3390\/ijms20143436","article-title":"Sphingolipid\/Ceramide pathways and autophagy in the onset and progression of melanoma: novel therapeutic targets and opportunities","volume":"20","author":"Lai","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2021.188675_bb0230","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1002\/1873-3468.13863","article-title":"The role of sphingolipids in endoplasmic reticulum stress","volume":"594","author":"Park","year":"2020","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbcan.2021.188675_bb0235","doi-asserted-by":"crossref","first-page":"jcs232850","DOI":"10.1242\/jcs.232850","article-title":"ER-associated degradation in health and disease - from substrate to organism","volume":"132","author":"Bhattacharya","year":"2019","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbcan.2021.188675_bb0240","doi-asserted-by":"crossref","DOI":"10.1017\/S0016672319000090","article-title":"Transmembrane emp24 domain proteins in development and disease","volume":"101","author":"Aber","year":"2019","journal-title":"Genet. Res."},{"key":"10.1016\/j.bbcan.2021.188675_bb0245","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.abb.2008.06.012","article-title":"Psychosine-induced alterations in peroxisomes of twitcher mouse liver","volume":"477","author":"Contreras","year":"2008","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bbcan.2021.188675_bb0250","doi-asserted-by":"crossref","first-page":"13730","DOI":"10.1523\/JNEUROSCI.3379-07.2007","article-title":"Autonomic denervation of lymphoid organs leads to epigenetic immune atrophy in a mouse model of krabbe disease","volume":"27","author":"Galbiati","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbcan.2021.188675_bb0255","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12943-021-01346-2","article-title":"Delivery of cancer therapies by synthetic and bio-inspired nanovectors","volume":"20","author":"Briolay","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbcan.2021.188675_bb0260","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3390\/nano9010105","article-title":"Vectors for Glioblastoma Gene Therapy: Viral & Non-Viral Delivery Strategies","volume":"9","author":"Caffery","year":"2019","journal-title":"Nanomaterials"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X21001736?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X21001736?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T04:40:03Z","timestamp":1759639203000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X21001736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S0304419X21001736"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2021.188675","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oncosuppressive and oncogenic activity of the sphingolipid-metabolizing enzyme \u03b2-galactosylceramidase","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2021.188675","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"188675"}}